Research Article
[Retracted] Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
Table 1
Association of FTO with clinical data of NSCLC patients (n, %).
| Index | Relative expression of FTO | value | High expression (n = 30) | Low expression (n = 30) |
| Age | ≥60 years (n = 33) | 13 | 20 | 0.069 | <60 years (n = 27) | 17 | 10 | Gender | Male (n = 35) | 20 | 15 | 0.190 | Female (n = 25) | 10 | 15 | Tumour size | ≥3 cm (n = 30) | 17 | 13 | 0.302 | <3 cm (n = 30) | 13 | 17 | Clinical stage | I + II (n = 37) | 13 | 24 | | III + IV (n = 23) | 17 | 6 | Lymph node metastasis | Yes (n = 18) | 14 | 4 | | None (n = 42) | 16 | 26 | Tumour type | Squamous cell carcinoma (n = 27) | 15 | 12 | 0.436 | Adenocarcinoma (n = 33) | 15 | 18 |
|
|
Note. denotes a notable difference. |